The frequency of Th17 cells (CD4+IL-17+) was reduced in both mild and severe COVID-19 group, whereas the frequency of Th2 cells (CD4+ IL-4+) was higher in both COVID-19 groups, compared to healthy donors. This evidence concerns the gene CD4 and COVID-19.